Yes. Although COVID-19 accelerated adoption, remote eConsent continues to be used across healthcare and research settings. It supports telehealth visits, clinical trials, and patient onboarding by allowing consent to be reviewed and completed remotely. Many organizations now use remote eConsent as part of standard workflows to improve efficiency, reduce in-person administrative steps, and give patients more time to review information before making decisions.
